Calorie reduction, not bypass surgery, ups diabetes control

Calorie reduction, not bypass surgery, ups diabetes control
Calorie reduction rather than the actual Roux-en-Y gastric bypass (RYGB) surgery seems to account for the improvement in glucose homeostasis in obese patients with type 2 diabetes who undergo RYGB, according to a study published online March 25 in Diabetes Care.

(HealthDay)—Calorie reduction rather than the actual Roux-en-Y gastric bypass (RYGB) surgery seems to account for the improvement in glucose homeostasis in obese patients with type 2 diabetes who undergo RYGB, according to a study published online March 25 in Diabetes Care.

Ildiko Lingvay, M.D., M.P.H., from the University of Texas Southwestern Medical Center in Dallas, and colleagues evaluated the contribution of versus surgically induced changes to glucose homeostasis for 10 patients with type 2 diabetes (age, 53.2 years; , 51.2 kg/m²) in two 10-day periods several months before and immediately after RYGB. Dietary intake was closely matched in the two periods, and patients served as their own controls.

The researchers found that during the presurgery period, the patients lost 7.3 kg compared with 4.0 kg during the postsurgery period (P = 0.01 between periods). Daily glycemia was significantly lower in the presurgery versus the postsurgery period (P = 0.02 between periods). During both periods the improvements in the fasting and maximum poststimulation glucose and six-hour glucose area under the curve (primary outcome) were similar.

" improved in response to a reduced caloric diet, with a greater effect observed in the absence of surgery as compared with after RYGB," write the authors. "These findings suggest that reduced calorie ingestion can explain the marked improvement in observed after RYGB."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Why can surgical treatment improve type 2 diabetes mellitus?

May 12, 2010

Roux-en-Y gastric bypass (RYGB) is a commonly used surgical treatment for patients with morbid obesity. It significantly and persistently decreases the levels of blood glucose and glycosylated hemoglobin in 80-100 percent ...

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

User comments